Tom Riffelmacher

@tom-riffel.bsky.social

Professor; University of Cologne; We research Immunometabolism, unconventional T cells, and cardio-oncology.

Seeking a junior scientist for scRNA-seq analytics in Cologne or remotely. If terms like Seurat, DimPlot, or ggplot2 spark recognition—or curiosity—you might be a fit.Flexible $$ Contract, Part time, MSc-to-PhD transition, or PhD project possible. Please feel free to reach out: triffelm@uni-koeln.de

A bit like spiralling publication costs we need to start having a proper discussion around lab equipment servicing costs. These are often completely disproportionate to the cost of instrument and the service that is provided and seem to serve as a cash cow for vendors.

"Immunometabolism, the intersection of cellular metabolism and immune function, has revolutionized our understanding of T cell biology." LJI experts share key discoveries from the growing field of immunometabolism! 👇 #Tcells #Cd1Mr12025

Tom Riffelmacher@tom-riffel.bsky.social · last yr.

Just in time for #Cd1Mr12025 Our Review on Innate-like T cell Metabolism is out! Access free here: rdcu.be/eEV67 Please share with your Immunometabolism friends! @cd1mr1.bsky.social @lji.org @uniklinikkoeln.bsky.social @natureportfolio.nature.com @natrevimmunol.nature.com

Horisberger et al separate Lupus nephritis patients in 3 groups by blood: healthy-like, interferon-dominant and CD8 T cell-dominant. The CD8 T cell-dominant group had the highest biopsy activity score and highest response rate after 1 year; the healthy-like the most chronic damage. 🧪 ⑂ #NephSky 1/

Bild

Bittersweet farewell weeks at @kiroxford.bsky.social, a place pivotal to my growth as an independent scientist. With deep gratitude for this chapter, I'm thrilled to begin the next at @unibas.ch @biomedizin.unibas.ch, where my lab will study organelle inheritance in T cells in the context of ageing.

Kennedy Institute of Rheumatology@kiroxford.bsky.social · last yr.

Dr Mariana Borsa (@nanaborsa.bsky.social), a postdoc studying autophagy and ageing, will leave the Kennedy Institute to start an exciting new chapter in Switzerland as a Principal Investigator!! 🎉 www.kennedy.ox.ac.uk/news/dr-mari...

In diabetic retinopathy, microvascular damage & inflammation disrupt the blood-retina barrier, but the role of microglia was unclear Thomas Langmann & team now show suppression of microglia-driven inflammatory responses preserves retinal integrity. buff.ly/2k5pD5W

Bild

This was a labor of love requiring lots of teamwork over years, repeating in 3 locations! Thanks to all the lab over the years, giving their time generously to this team project, & our wonderful collaborators. The source of fat matters for anti-tumor immunity 🐄🐖🧈🌴🫒🥥 www.nature.com/articles/s42...

The source of dietary fat influences anti-tumour immunity in obese mice - Nature Metabolism

This study shows that animal-based high-fat diets accelerate tumour growth and impair anti-tumour response to melanoma in obese mice, whereas plant-based high-fat diets do not.

nature.com

Forget Trump & Musk's bromance...join us at Keystone's Immunometabolism Across Scales: From Cells to Systems to Healthspan! Super science, discussions and colleagues. Be there- Vancouver, BC Jan 11-14, 2026. Keynotes: Amazing Drs. Dana Pe'er and Marcia Haigis!! Speaker line-up is GOAT!

Bild

A huge congratulations to LJI's Dr. Tom Riffelmacher! Tom's work has helped reveal a whole new side of T cells, and we are thrilled to see what he does next! 🎉

Tom Riffelmacher@tom-riffel.bsky.social · last yr.

I am not dreaming, it’s official! I am starting my lab as Professor in the department of medicine III at @unicologne.bsky.social We will explore the immunometabolic control of unconventional lymphocytes in cancer and cardiovascular disease. WE ARE HIRING AT ALL LEVELS (MTA/BTA, postdoc, PHD)